Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)
1.500
-0.010
(-0.66%)
Streaming Delayed Price
Updated: 9:30 AM EDT, Oct 17, 2025
Add to My Watchlist
Headline News about Inhibikase Therapeutics, Inc. - Common Stock
Inhibikase Posts Wider Loss in Q2
August 14, 2025
Via The Motley Fool












Dow Jumps Over 100 Points; Helen Of Troy Posts Upbeat Q2 Results
October 09, 2024












Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.